Role of Magnesium Supplementation in Children with West Syndrome: A Randomized Controlled Clinical Trial
Iranian Journal of Child Neurology,
Vol. 16 No. 1 (2022),
1 January 2022
,
Page 65-75
https://doi.org/10.22037/ijcn.v16i1.30480
Abstract
Abstract
Objectives
West syndrome is a severe epileptic encephalopathy of young age. It is characterized by a clinico-electrical triad of infantile epileptic spasms, regression or arrest of psychomotor development, and hypsarrhythmia. In the last two decades, the large progress in the development of newer antiepileptic drugs has allowed us to have a vast choice of treatment options to control spasms, although they often fail to do so. Thus, there is a need to explore other treatment options.
Materials & Methods
Subjects in this open-labelled randomized control trial were included newly diagnosed children of age between 3 months and 5 years of both genders. A total of 52 children were recruited and randomized into two groups: an intervention group (n=30) and a non-intervention group (n=22). Magnesium sulphate was provided for the intervention group but not for the non-intervention one. Both groups received the rest of the treatments, including adrenocorticotropic hormone and antiepileptic drugs. The follow-up period was three months, at the end of which a per-protocol analysis was performed.
Results
There was no significant difference in seizure control and neurodevelopmental outcome between both groups, but electroencephalogram significantly improved in the intervention group compared to the control. Also, the clinical response was better in patients with normal initial serum magnesium levels in the intervention group (p=0.003) than in other patients.
Conclusion
Magnesium supplementation may be helpful in children with West syndrome
- Magnesium supplementation
- West syndrome
- Seizures
How to Cite
References
Lux, A. L., and Osborne, J. P. A proposal for case definitions and outcome measures in studies of
infantile spasms and west syndrome: consensus statement of the west Delphi group. Epilepsia
; 45: 1416–1428.
Fukuyama Y: A special note on terminology of West syndrome and infantile spasms. Brain Dev. 2001;23:442.
Kalra V. Gulati S. West syndrome and other infantile epileptic encephalopathies- Indian hospital experience. Brain Dev. 2002;23(L7):593-602.
Hancock EC, Osborne JP, Edwards SW. Treatment of infantile spasms. Cochrane Database syst. Rev. 2008;CD001770.
Tsao, CY. Current trends in the treatment of infantile spasms. Neuropsychiatr Dis Treat. 2009;5:289-299.
Sinert R, Zehtabchi S, Desai S, Peacock P, Altura BT, Altura BM. Serum ionized magnesium and calcium levels in adult patients with seizures. Scand J Clin Lab Invest. 2007;67(3):317-26.
Gupta SK, Manhas AS, Gupta VK, Bhatt R. Serum magnesium levels in idiopathic epilepsy. J Assoc Physicians India. 1994;42(6):456-7.
Oladipo OO, Lesi FE, Ezeaka VC. Plasma magnesium and calcium levels in children with epilepsy in lagos. Niger Postgrad Med J.2007;14(1):26-9.
Miyamato Y, Yamamoto H, Murakami H, Kamiyama N, Fukuda M. Studies on cerebrospinal fluid ionized calcium and magnesium concentrations in conclusive children. Pediatr Int. 2004;46(4);394-7.
Prebble JJ. Primary infantile hypomagnesenia: report of two cases. Paediatr Child Health. 1995;31(1):54-6.
Carney PR, Dharnidharka VR. Isolated idiopathic hypomagnesemia presenting
as aphasia and seizures. Pediatr Neurol. 2005;33(1):61-5 .
Leaver DD, Parkinson GB, Schneider KM. Neurological consequences of magnesium deficiency: correlations with epilepsy. Clin Exp Pharmacol Physiol. 1987;14(5):361-70.
Lynch BJ, Rust RS. Natural history and outcome of neonatal hypocalcemic and hypomagnesemic seizures. Pediatr Neurol. 1994;11(1):23-7.
McDonald JW, Silverstein FS, Johnston MW. Magnesium reduces N-methyl-D-aspartate (NMDA)-mediated brain injury in perinatal rats. Neurosci Lett. 1990;109(1-2):234-8.
Yuen AW, Sander JW. Can magnesium supplementation reduce seizures in people with epilepsy? A hypothesis. Epilepsy Res. 2012;100(1-2):152-156 .
Carlen PL, Abdelmalik PA, Politzer N. Magnesium as an effective adjunct therapy for drug resistant seizures. Clin J Neurol Sci. 2012;39(3):323-7.
Van den Bergh WM, Visser NA, Braun KP, Leijten FS, van Nieuwenhuizen O, Wokke JH, Magnesium treatment for patients with refractory status epilepticus due to POLG1- mutations. J Neurol. 2011;258(2):218-22.
Zou LP, Wang X, Dong CH, Chen CH, Zhao W, Zhao RY. Three week combination treatment with ACTH+ magnesium sulfate versus ACTH monotherapy for infantile spasms: a 24-weeks, randomized, open-label, follow up study in China. Clin Ther. 2010;32(4):692-700.
Mackay M. Practice Parameter: Medical Treatment of Infantile Spasms: Report of the American Academy of Neurology and the Child Neurology Society. Neurology. 2004; 62(10):1668-1681.
Singhi P, Ray M. Profile of West syndrome in North Indian children. Brain Dev. 2005; 27: 135–140.
Nelson G R. Management of infantile spasms. Transl Pediatr. 2015 Oct; 4(4): 260–270.
Wan L, Yang G, Zou LP, Wang J, Shi XY, Ren WH, Lu Q. Factors in first-time adrenocorticotropic hormone therapy and their influence on spasm control time in infantile spasms: a Cox proportional-hazards regression model analysis. CJCP 2019 Sep;21(9):845-850.
- Abstract Viewed: 562 times